Assessing Neuro-Oncology Disease in Pediatric Clinical Trials

Learn how the use of standardized imaging protocols with appropriate radiological and clinical response assessments (based on tumor characteristics) can improve the robustness of clinical trial data and the chances to obtain positive results in pediatric neuro-oncology trials.

Read More

Share Post

twitter Facebook



Detecting Myocarditis in Oncology Trials with Imaging

Advanced imaging techniques can be used to assess for myocarditis (which has been reported with immune checkpoint inhibitors) before initiating cancer therapy, as well as for monitoring during and after treatment.

Read More

Share Post

twitter Facebook


Using Cardiac Imaging to Identify Cardiovascular Treatment-related Effects during Oncology Clinical Trials

The importance of evaluating cardiotoxicity during the clinical development of therapeutic agents cannot be understated. In this first of a 2-part series, we review several imaging methods that can support cardiac safety endpoints in oncology clinical trials and how imaging core labs can assist trial sponsors in evaluating these advanced techniques for incorporation into study protocols.

Read More

Share Post

twitter Facebook

Navigating the Response Assessment Criteria for Lymphoma

Learn how recent changes to the standard treatment response criteria used in lymphoma clinical trials ─ including new biomarkers and different imaging methods ─ are enabling more accurate and effective patient assessment and management.

Read More

Share Post

twitter Facebook